Quick answers
- What is 2% Lidocaine Hci?
- 2% Lidocaine Hci is a brand name of Lidocaine, a prescription medicine. The FDA NDC Directory lists 3 2% Lidocaine Hci products in 2 strengths and forms.
- Who makes 2% Lidocaine Hci?
- Hospira holds the FDA application for 2% Lidocaine Hci (ANDA083158, approved October 31, 1972). 1 other company (repackagers or distributors) also list 2% Lidocaine Hci products.
- Is there a generic or store brand of 2% Lidocaine Hci?
- Yes. The FDA NDC Directory lists 112 other products with the same active ingredients, strength and form as a 2% Lidocaine Hci product, 108 of them generic. Ask your pharmacist whether one is right for you.
- Has 2% Lidocaine Hci been recalled?
- No recall linked to 2% Lidocaine Hci products (by their NDC code or label) appears in the FDA enforcement reports we use.
What 2% Lidocaine Hci is
Each 2% Lidocaine Hci product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Lidocaine · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| lidocaine hydrochloride 20 mg/mL injection, solution (infiltration, perineural) | 2% Lidocaine Hci | 56 products, 17 companies | DailyMed |
| lidocaine hydrochloride 20 mg/mL injection, solution (intravenous) | 2% Lidocaine Hci | 56 products, 17 companies | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Lidocaine →
FDA approval
- ANDA: Abbreviated New Drug Application: how a generic version is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| ANDA083158 | Hospira | October 31, 1972 | 1 |
| ANDA088327 | Hospira | July 31, 1984 | 2 |
Companies that list 2% Lidocaine Hci
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of 2% Lidocaine Hci products.
Recalls
No recall linked to 2% Lidocaine Hci products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.